Skip to main content
Log in

Commentary: Current Perspectives on the Aggregation of Protein Drugs

  • Commentary
  • Theme: Aggregation and Interactions of Therapeutic Proteins
  • Published:
The AAPS Journal Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Teuscher A. Insulin: a voice for choice. Basel: Karger Publishers; 2007.

    Google Scholar 

  2. Shi S, Liu J, Joshi SB, Krasnoperov V, Gill P, Middaugh CR, et al. Biophysical characterization and stabilization of the recombinant albumin fusion protein sEphB4-HSA. J Pharm Sci. 2012;101(6):1969–84.

    Article  CAS  PubMed  Google Scholar 

  3. Cheng W, Joshi SB, He F, Brems DN, He B, Kerwin BA, et al. Comparison of high-throughput biophysical methods to identify stabilizing excipients for a model IgG2 monoclonal antibody: conformational stability and kinetic aggregation measurements. J Pharm Sci. 2012;101(5):1701–20.

    Article  CAS  PubMed  Google Scholar 

  4. Kumru OS, Liu J, Ji JA, Cheng W, Wang J, Wang T, et al. Compatibility, physical stability, and characterization of an IgG4 monoclonal antibody after dilution into different intravenous administration bags. J Pharm Sci. 2012;101(10):3636–50.

    Article  CAS  PubMed  Google Scholar 

  5. Lubiniecki A, Volkin DB, Federici M, Bond MD, Nedved ML, Mehndiratta P, et al. Comparability assessments of process and product changes made during development of two different monoclonal antibodies. Biologicals. 2011;39:9–22.

    Article  CAS  PubMed  Google Scholar 

  6. Alsenaidy MA, Wang T, Kim JH, Joshi SB, Lee J, Blaber M, et al. An empirical phase diagram approach to investigate conformational stability of “second-generation” functional mutants of acidic fibroblast growth factor-1. Protein Sci. 2012;21(3):418–32.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Chaudhuri R, Cheng Y, Middaugh CR, Volkin DB. High-throughput biophysical analysis of protein therapeutics to examine interrelationships between aggregate formation and conformational stability. AAPS J. 2014;16(1):48–64.

    Article  CAS  PubMed  Google Scholar 

  8. Roberts CJ, Darrington RT, Whitley MB. Irreversible aggregation of recombinant bovine granulocyte-colony stimulating factor (bG-CSF) and implications for predicting protein shelf life. J Pharm Sci. 2003;92(5):1095–111.

    Article  CAS  PubMed  Google Scholar 

  9. Sahin E, Weiss WF, Kroetsch AM, King KR, Kessler RK, Das TD, et al. Aggregation and pH-temperature phase behavior for aggregates of an IgG2 antibody. J Pharm Sci. 2012;101(5):1678–87.

    Article  CAS  PubMed  Google Scholar 

  10. Wang W, Roberts CJ. Non-Arrhenius protein aggregation. AAPS J. 2013;15(3):840–51.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Wei B, Rogers BJ, Wirth MJ. Slip flow in colloidal crystals for ultraefficient chromatography. J Am Chem Soc. 2012;134:10780–2.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Njoya NK, Birdsall RE, Wirth MJ. Silica colloidal crystals as emerging materials for high-throughput protein electrophoresis. AAPS J. 2013;15(4):962–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elizabeth M. Topp.

Additional information

Guest Editor: Craig Svensson

Rights and permissions

Reprints and permissions

About this article

Cite this article

Topp, E.M. Commentary: Current Perspectives on the Aggregation of Protein Drugs. AAPS J 16, 413–414 (2014). https://doi.org/10.1208/s12248-014-9580-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12248-014-9580-0

Keywords

Navigation